Results of the previous case‐control study demonstrated that IGF2BP2 rs4402960 G > T was involved in the risk of cancer.22, 23 In addition, Liu et al24 found that IGF2BP2 variants might be an independent predictor of chemotherapeutic response in patients with metastatic gastric cancer. The gene discussed is IGF2BP2; the disease is cancer.